NVO Competitors & Alternatives
Compare Novo Nordisk A/S with similar stocks in the same industry
Drug Manufacturers - General
NVO
Main Stock$46.74
Tradestie Score
49
Market Cap
$262.92B
P/E Ratio
11.4
Revenue Growth
0.0%
Analyst Upside
+1.8%
Top Competitors
20 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
UNH
UNITEDHEALTH GROUP INCORPORATED (Delaware)
|
$390.11
|
$315.45B | 25.3 | 50 | Compare |
|
AZN
AstraZeneca PLC
|
$165.98
|
$261.56B | 24.7 | 68 | Compare |
|
NVS
Novartis AG
|
$158.86
|
$254.99B | 23.6 | 50 | Compare |
|
MRK
Merck & Co., Inc.
|
$152.55
|
$225.13B | 122.1 | 45 | Compare |
|
AMGN
Amgen Inc
|
$439.33
|
$160.70B | 27.5 | 38 | Compare |
|
PFE
Pfizer Inc.
|
$28.07
|
$154.70B | 35.7 | 40 | Compare |
|
GILD
Gilead Sciences Inc
|
$146.12
|
$137.92B | - | 34 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$45.85
|
$121.27B | 23.4 | 34 | Compare |
|
BMY
Bristol-Myers Squibb Co.
|
$67.01
|
$96.54B | 14.4 | 37 | Compare |
|
GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
|
$52.41
|
$91.59B | 16.3 | 54 | Compare |
More NVO Analysis
Data updated: Aug 24, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
20 stocks in this industry